<?xml version="1.0" encoding="UTF-8"?>
<p id="p0225">At present, there is no evidence to support the effectiveness of antiviral drugs for COVID-19, although these are commonly used in the treatment of COVID-19 in China. The guidelines of the NHC recommend interferon-α2b inhalation, lopinavir/ritonavir, ribavirin, chloroquine, and arbidol as antiviral therapy and does not recommend using more than 2 antiviral drugs at the same time (
 <xref rid="tbl3" ref-type="table">Table 3</xref> ).
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib36" ref-type="bibr">
  <sup>36</sup>
 </xref>
</p>
